Evidence map›Paper›PMID 38463109›Full record

ReviewAnnals of medicine and surgery (2012)2024

Japanese encephlu emergence in Australia: the potential population at risk.

Afsheen Khan, Rumaisa Riaz, Abdullah Nadeem, Ayesha Amir, Tasmiyah Siddiqui, Um E A Batool, Nahid Raufi

Abstract readReview
In one paragraph

Review in Annals of medicine and surgery (2012), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Afsheen KhanDepartment of Medicine, Dow University of Health Sciences, Karachi, Pakistan.
Rumaisa RiazDepartment of Medicine, Dow University of Health Sciences, Karachi, Pakistan.
Abdullah NadeemDepartment of Medicine, Dow University of Health Sciences, Karachi, Pakistan.
Ayesha AmirDepartment of Surgery, Hamad Medical Corporation.
Tasmiyah SiddiquiDepartment of Medicine, Dow University of Health Sciences, Karachi, Pakistan.
Um E A BatoolDepartment of Medicine, Dow University of Health Sciences, Karachi, Pakistan.
Nahid RaufiDepartment of Medicine, Kabul Medical University, Afghanistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Japanese encephalitis virus (JEV), an RNA virus transmitted by Culex mosquitoes, primarily cycles between aquatic birds and mosquitoes with pigs as amplifying hosts, posing a significant global encephalitis threat. The emergence and spread of the JEV in new epidemiological regions, such as recent cases in Australia and nonendemic areas like Pune, India, raise significant concerns. With an estimated 68 000 clinical cases and 13 600 to 20 400 deaths annually, JEV poses a substantial global health threat. The virus primarily affects children, with a case-fatality ratio of 20-30% and long-term neurological sequelae in survivors. The changing epidemiology, influenced by factors like bird migration, climate change, and increased urbanization, contributes to the geographic expansion of JEV. The recent outbreaks underscore the potential for the virus to establish itself in nonendemic regions, posing a threat to populations previously considered at low-risk. With limited treatment options and high rates of neurological complications, continued surveillance, traveler vaccination, and research into treatments are crucial to mitigate the impact of JEV on human health. The evolving scenario necessitates proactive measures to prevent and control the spread of the virus in both endemic and newly affected areas.

Indexed as

epidemiologyflavivirusglobal impactJapanese encephalitis virus (JEV)reservoir hoststransmission cyclevector mosquito

Identifiers

PMID38463109
PMCPMC10923274

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.